Thomas Reiberger

Thomas Reiberger is a Professor for Gastroenterology and Hepatology at the Medical University of Vienna and an adjunct PI at CeMM. He leads the Vienna Hepatic Experimental Hemodynamic (HEPEX) Laboratory, focusing on liver fibrosis and portal hypertension. His clinical roles include directing the Liver Outpatient Clinic and Vienna Hepatic Hemodynamic Laboratory at MedUni Vienna.

• Primary Affiliation: Medical University of Vienna (Department of Internal Medicine III, Division of Gastroenterology and Hepatology)
• Research Institute: CeMM (adjunct PI)
• Laboratory: Vienna Hepatic Experimental Hemodynamic Lab (HEPEX Lab)

His research spans liver fibrogenesis, portal hypertension, and vascular abnormalities in liver disease. Key publications highlight work on FXR agonists, anti-angiogenic drugs, and hemodynamic modulation in cirrhosis. The Christian Doppler Laboratory under his leadership explores molecular mechanisms of fibrosis and vascular dysfunction.

Major collaborations include Boehringer Ingelheim, CeMM, and LBI-RUD. He coordinates the European Reference Network (ERN) RARE-LIVER and directs the clinical program for advanced chronic liver disease and transplant hepatology.